CMRXEUR
Chimerix, Inc.
A biopharmaceutical company in Durham, North Carolina, that develops medicines for serious diseases. Founded in 2000, it made its name on lipid-conjugated antivirals — its smallpox drug Tembexa attached fat molecules to an existing antiviral to help it reach cells. It later pivoted to brain cancer, winning 2025 FDA approval for Modeyso, a therapy for a rare childhood brain tumor, before being bought by Jazz Pharmaceuticals. Its name blends "chimera," a creature of mixed parts, with an "x" for experiment.
CUSIP: 16934W106HealthcareUS1 holder
Total Value
$7.71M
Total Shares
1.21M
Net Share Change
+162.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
